BioLife Solutions, Inc. Long-Term Debt, Maturity, Remainder of Fiscal Year
BioLife Solutions, Inc. (BLFS) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $2.50 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2026-05-07
- 2026-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $2.50M.
- 2025-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $2.50M.
- 2025-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $5.05M.
- 2025-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $7.95M.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2026-03-31 | $2.50M 10-Q · filed 2026-05-07 |
| 2025-09-30 | $2.50M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $5.05M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $7.95M 10-Q · filed 2025-05-08 |
| 2024-09-30 | $3.18M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $5.34M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $5.97M 10-Q · filed 2024-05-10 |
| 2023-09-30 | $816.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.22M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.14M 10-Q · filed 2023-05-11 |
| 2022-09-30 | $679.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $759.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $432.00K 10-Q · filed 2022-05-10 |
| 2021-09-30 | $950.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.35M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $1.30M 10-Q · filed 2021-05-17 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |